HCPCS Level II
C9081
Idecabtagene vicleucel, up to 460 million autologous anti-bcma car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
- Category
- C. Outpatient PPS, temporary
- NDC crosswalk
- None in the loaded CMS ASP file
Codes near C9081
These sit next to C9081 in the CMS Level II file. All C codes
- C9076Lisocabtagene maraleucel, up to 110 million autologous anti-cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
- C9077Injection, cabotegravir and rilpivirine, 2mg/3mg
- C9078Injection, trilaciclib, 1 mg
- C9079Injection, evinacumab-dgnb, 5 mg
- C9080Injection, melphalan flufenamide hydrochloride, 1 mg
- C9082Injection, dostarlimab-gxly, 100 mg
- C9083Injection, amivantamab-vmjw, 10 mg
- C9084Injection, loncastuximab tesirine-lpyl, 0.1 mg
- C9085Injection, avalglucosidase alfa-ngpt, 4 mg
- C9086Injection, anifrolumab-fnia, 1 mg